Rajiv Kumar Bedi (Rajiv K Bedi)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Capillary Electrophoresis

Molecular Dynamics

Top Venues

Journal of medicinal chemistry

ACS bio & med chem Au

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry 67 (11) (2024)
František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry (2024)
František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry 67 (11) (2024)
František Zálešák, Francesco Nai, Marcin Herok, Elena Bochenkova, Rajiv Kumar Bedi, Yaozong Li, Francesco Errani, Amedeo Caflisch
Structure-Based Design of a Potent and Selective YTHDC1 Ligand. Journal of medicinal chemistry 67 (11) (2024)
Ivan Corbeski, Pablo Andrés Vargas-Rosales, Rajiv Kumar Bedi, Jiahua Deng, Dylan Coelho, Emmanuelle Braud, Laura Iannazzo, Yaozong Li, Danzhi Huang, Mélanie Ethève-Quelquejeu, Qiang Cui, Amedeo Caflisch
The catalytic mechanism of the RNA methyltransferase METTL3. bioRxiv : the preprint server for biology (2023)
Rajiv Kumar Bedi, Danzhi Huang, Yaozong Li, Amedeo Caflisch
Structure-Based Design of Inhibitors of the m 6 A-RNA Writer Enzyme METTL3. ACS bio & med chem Au 3 (4) (2023)